Ebselen (SPI-1005) | VDCC Inhibitor

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

CAS No. :	60940-34-3
Formula :	C₁₃H₉NOSe
M.W :	274.18
SMILES Code :	O=C1N(C2=CC=CC=C2)[Se]C3=CC=CC=C13
Synonyms :	SPI-1005; PZ-51; DR 3305
InChI Key :	DYEFUKCXAQOFHX-UHFFFAOYSA-N
Pubchem ID :	3194

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H301+H331-H373-H410
Precautionary Statements:	P260-P264-P270-P271-P273-P301+P310+P330-P304+P340+P311-P314-P391-P403+P233-P405-P501
Class:	6.1
UN#:	3283
Packing Group:	Ⅲ

Bone marrow macrophages (BMMs)	10 µM	1 day	Ebselen suppressed RANKL-induced osteoclast differentiation by reducing the phosphorylation of IκB, PI3K, and Akt, thereby decreasing the expression of c-Fos and NFATc1.	PMC4807414
RAW264.7 cells	8 μg/mL	1 hour	Ebselen significantly suppressed the expressions of inflammatory mediators (IL-1β, IL-6, TNF-α, COX-2, iNOS, and CCL2) and reduced the production of oxidative stress-associated indicators (ROS, NO, and MDA) in fungi-stimulated RAW264.7 cells.	PMC11152752
Bone marrow macrophages (BMMs)	10 µM	2 days	Ebselen induced apoptosis of osteoclasts in the late stage of osteoclast differentiation by activating caspase-3 and caspase-9.	PMC4807414
L6 myotubes	10 µM	20-24 hours	Ebselen reduces the catalytic activity of SHIP2 and enhances insulin-induced phosphorylation of Akt	PMC8935241
Hepatoma cells (Fao cells)	10 µM	20-24 hours	Ebselen reduces the catalytic activity of SHIP2	PMC8935241
HCECs	4–18 μg/mL	24 hours	Ebselen promoted cell proliferation at low concentrations (?8 μg/mL) and gradually showed cytotoxic effects at high concentrations (?10 μg/mL).	PMC11152752
Human Gingival Fibroblasts (HGFs)	10 μM	24 hours	To evaluate the cytotoxicity of Ebselen combined with AgNPs on HGFs, results showed that Ebselen combined with AgNPs up to 20 μg/mL showed no obvious cytotoxicity	PMC10759458
Human Gingival Fibroblasts (HGFs)	10 μM	4 hours	To evaluate the intracellular bactericidal efficiency of Ebselen combined with silver nanoparticles (AgNPs), results showed that Ebselen significantly enhanced the intracellular bactericidal efficiency of AgNPs	PMC10759458

C57BL/Ks-db/db mice	db/db diabetic mice	Oral	10 mg/kg/day	Once daily for 10 weeks	Ebselen reduces the activity of SHIP2, improves insulin sensitivity, and decreases lipid peroxidation and inflammation in the liver	PMC8935241
C57BL/6 mice	Fungal keratitis model	Topical administration	8 μg/mL	4 times per day for 3 days	Ebselen improved the prognosis of mouse fungal keratitis, reduced the fungal burden in mouse corneas, and significantly decreased the expressions of inflammatory mediators as well as the infiltration of macrophages and neutrophils in the cornea.	PMC11152752
ICR mice	LPS-induced inflammatory bone loss model	Oral	10 mg/kg	Every 8 days for 8 days	Ebselen restored LPS-induced bone loss and reduced TRAP-positive osteoclast formation in bone tissues.	PMC4807414
C57BL/6 mice	5-HT2A receptor function model	Intraperitoneal injection	1, 5, 10 mg/kg	Acute administration or repeated administration (7 days, twice daily)	Ebselen inhibited the behavioural responses (head-twitches and ear scratches) and molecular responses (immediate early gene expression) induced by the 5-HT2A receptor agonist DOI, and enhanced the increase in extracellular 5-HT induced by the SSRI citalopram.	PMC6003638
BALB/c mice	Cigarette smoke exposure model	Oral	10 mg/kg	Once daily for 8 weeks	Ebselen significantly reduced cigarette smoke-induced lung inflammation and vascular oxidative stress, and restored vascular endothelial function.	PMC8074626
BALB/c mice	Cigarette smoke-induced COPD model	Oral gavage	10 mg/kg	Daily for 2 or 6 months	Ebselen treatment improved the CS-induced reduction in colonic diameter	PMC7676466
BALB/c mice	Chronic cigarette smoke exposure and influenza A virus infection model	Oral gavage	10 mg/kg	Once daily for 3 or 10 days	Ebselen abolished the vascular dysfunction caused by influenza A virus in chronic cigarette smoke-exposed mice, and alleviated lung inflammation and T cell infiltration.	PMC9069468
BALB/c mice	Cigarette smoke exposure and influenza A virus infection model	Oral gavage	10 mg/kg	Daily for 8 weeks	Ebselen significantly alleviated the endothelial dysfunction and inflammation induced by cigarette smoke and influenza A virus infection, and reduced T cell infiltration in the aortic wall.	PMC9069468
Wistar rats	Experimental periodontitis model	Local injection	500 μM	Every other day for 2 weeks	To evaluate the therapeutic effects of Ebselen combined with AgNPs on experimental periodontitis, results showed that Ebselen combined with AgNPs significantly reduced gingival inflammation and alveolar bone resorption	PMC10759458

Alternative Products

Product Details of Ebselen

Safety of Ebselen

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02779192	Noise Induced Hearing Loss	Phase 2	Not yet recruiting	October 2021	United States, Florida ... More >> University of Miami Not yet recruiting Miami, Florida, United States, 33136 Contact: Michael Hoffer, MD United States, Kansas University of Kansas Medical Center Not yet recruiting Kansas City, Kansas, United States, 66103 Contact: Hinrich Staecker, MD/PhD United States, South Carolina MUSC Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Southwestern Not yet recruiting Dallas, Texas, United States, 75390 Contact: Joe Kutz, MD United States, Washington Sound Pharmaceuticals, Inc. Seattle, Washington, United States, 98103 Less <<
NCT01451853	Lung Cancer H... More >>ead and Neck Cancer Hearing Loss Ototoxicity Tinnitus Neuropathy Less <<	Phase 2	Not yet recruiting	September 23, 2019	United States, Washington ... More >> VA Puget Sound Health Care Not yet recruiting Seattle, Washington, United States, 98108 Contact: Tony S. Quang, M.D. 206-768-5356 Principal Investigator: Tony S Quang, M.D. Less <<
NCT03325790	Meniere's Disease	Phase 2	Recruiting	December 2018	United States, District of Col... More >>umbia Georgetown University Recruiting Washington, District of Columbia, United States, 20057 Contact: Study Director United States, Kentucky Advanced ENT & Allergy Recruiting Louisville, Kentucky, United States, 40207 Contact: Study Director United States, New York ENT and Allergy Associates, LLP Recruiting New York, New York, United States, 10017 Contact: Study Director United States, South Carolina MUSC Recruiting Charleston, South Carolina, United States, 29425 Contact: Study Director United States, Texas UT Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Study Director United States, Washington Northwest Ear, Inc. Recruiting Seattle, Washington, United States, 98104 Contact: Study Director Less <<
NCT01444846	Temporary Auditory Threshold S... More >>hift Less <<	Phase 2	Completed	-	United States, Florida ... More >> University of Florida Gainsville, Florida, United States, 32610 Less <<
NCT02819856	Ototoxicity	Phase 1 Phase 2	Enrolling by invitation	September 2019	United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00762671	Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less <<	Phase 2 Phase 3	Completed	-	United States, Massachusetts ... More >> Brigham and Women's Hosptial Boston, Massachusetts, United States, 02115 Less <<
NCT01452607	Hearing Loss ... More >>Cancer Less <<	Phase 1	Completed	-	United States, Nebraska ... More >> MDS Pharma Services Lincoln, Nebraska, United States, 68502 Less <<
NCT03013400	Bipolar Disorder ... More >> Bipolar Disorder, Manic Less <<	Phase 2	Recruiting	June 2020	United Kingdom ... More >> Neurosciences Building, Dept. Psychiatry, Warneford Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX37JX Contact: Ann L Sharpley, PhD 01865 618321 ann.sharpley@psych.ox.ac.uk Contact: Clare Williams, RMN 01865 618315 clare.williams@psych.ox.ac.uk Principal Investigator: Philip J Cowen, FRCPsych Less <<
NCT02603081	Meniere's Disease	PHASE1\|PHASE2	COMPLETED	2025-08-17	House Clinic, Los Angeles, Cal... More >>ifornia, 90057, United States\|New York Otology, New York, New York, 10028, United States\|MUSC, Charleston, South Carolina, 29425, United States\|Sound Pharmaceuticals, Inc., Seattle, Washington, 98103, United States\|Northwest Ear, Seattle, Washington, 98104, United States Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.65mL 0.73mL 0.36mL	18.24mL 3.65mL 1.82mL	36.47mL 7.29mL 3.65mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed